Castle Biosciences (CSTL) Interest Expenses (2018 - 2026)

Castle Biosciences has disclosed Interest Expenses across 9 years of filings, most recently posting $134000.0 for Q1 2026.

• Interest Expenses for Q1 2026 came in at $134000.0, up 688.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $203000.0 (down 65.0% YoY), and the FY2025 annual result was $86000.0, down 85.1% from the prior year.
• Interest Expenses came in at $134000.0 for Q1 2026 at Castle Biosciences, up from $24000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $270000.0 in Q2 2024 to a low of $2000.0 in Q3 2023.
• The 5-year median for Interest Expenses is $12000.0 (2024), against an average of $48411.8.
• Across the five-year window, Interest Expenses surged 9950.0% in 2024 and sank 92.22% in 2025, its largest moves.
• Castle Biosciences' Interest Expenses stood at $4000.0 in 2022, then slumped by 50.0% to $2000.0 in 2023, then surged by 4500.0% to $92000.0 in 2024, then slumped by 73.91% to $24000.0 in 2025, then surged by 458.33% to $134000.0 in 2026.
• The last three Interest Expenses figures came in at $134000.0 (Q1 2026), $24000.0 (Q4 2025), and $24000.0 (Q3 2025), per Business Quant data.